deltatrials
Completed NCT04298619

Follow Up of High Risk Hodgkin Lymphoma in First Complete Remission

Impact on Survival of Early Detection of Recurrence in the Follow Up of High Risk Hodgkin Lymphoma in First Complete Remission

Sponsor: Federico II University

Conditions High Risk Hodgkin Lymphoma Relapse
Interventions Imaging cohort: integrated imaging follow-up Standard cohort: Clinical lab follow-up
Updated 4 times since 2020 Last updated: Mar 4, 2020 Started: Jun 30, 2001 Primary completion: Apr 30, 2016 Completion: Apr 30, 2019

This observational or N/A phase trial investigates High Risk and Hodgkin Lymphoma and is currently completed. Federico II University leads this study, which shows 4 recorded versions since 2001 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Change History

4 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed

  2. Jul 2024 — Sep 2024 [monthly]

    Completed

  3. Jan 2021 — Jul 2024 [monthly]

    Completed

  4. Apr 2020 — Jan 2021 [monthly]

    Completed

    First recorded

Jun 2001

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Federico II University
Data source: Federico II University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.